That's right. Dendreon wasn't "manipulated into bankruptcy" like these conspiracy theories claim. Its sole drug Provenge had limited efficacy compared to competitor prospective treatments, a huge price, reimbursement issues, and the company over-borrowed ($ billions) for manufacturing based on sales projections that didn't materialize. Savvy investors saw this coming and smartly stayed away, and everyone else cried "basher" and "naked shorter" and got badly hurt. Pays to be a savvy investor, not a conspiracy theorist.
News 
Market Data 
Discover 
AI
